Company profile
CC Biotech LTD.
403 Forbidden
CC Biotech LTD. is a UK company with status active founded in 2018 based in East of England.
Company events
Reference milestones and recent Companies House filing stream events.
Accounts due
Accounts DueNext accounts due date
Confirmation statement due
Confirmation DueNext confirmation statement due date
Confirmation statement filed
ConfirmationLast confirmation statement made up date
Accounts filed
AccountsLast accounts made up date
Confirmation Statement With Updates
Confirmation-statementCS01 | Transaction MzQzMzg0NDgyMmFkaXF6a2N4
Published 29 Aug 2024 17:08
Accounts With Accounts Type Total Exemption Full
Accounts Awaiting analysisAA | Transaction MzQzMjUwODk2MmFkaXF6a2N4
Published 16 Aug 2024 14:30
Incorporated
InceptionCompany registered at Companies House
Public funding
Projects
Novel Biomanufacturing Strategies for Scalable Production of Non-Donor-Derived FMT Products
1 Jul 2025 to 31 Mar 2028
**The Bacterial Microbiome: Key to our Health** Bacteria from a critical element of who we are: indeed, we carry approximately the same amount of bacterial cells around with us as the human cells which make up our body. These bacteria that grow and thrive on all of our internal and external surfaces are known as our microbiome. We play host to several dif...
Treatment of Recurrent Bacterial Vaginosis Using Engineered Probiotic Bacteria
1 Jan 2023 to 31 Jan 2025
**Public description** This project aims to develop new therapies for the prevention of recurrent bacterial vaginosis (BV). Around 30% of women suffer from BV, making it the most common vaginal infection of women of childbearing age. BV is caused by the overgrowth of unwanted bacteria within the vagina. The main problematic bacterium which causes BV is ca...
Continuity Grant for Project 105472/37800
1 Jun 2020 to 30 Nov 2020
no public description
Development of clinically translatable therapies for the treatment and prevention of bacterial vaginosis
1 Feb 2020 to 31 Oct 2021
This research aims to develop new therapies for the treatment of recurrent bacterial vaginosis (BV). BV is the most common vaginal infection experienced by women of childbearing age, with up to 30% of woman of this group affected by the condition. BV is caused by the overgrowth of unwanted bacteria within the vagina. The main problematic bacterium which c...